INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2013

Turmeric shows efficacy against ailments such as lupus nephritis, cancer, diabetes, and irritable bowel syndrome in clinical trials.

This review examines the chemical constituents, biological activities, molecular targets, and clinical potential of turmeric. Curcumin constitutes 2-5% of turmeric, though some activities of turmeric are curcumin-independent. Clinical trials have demonstrated the efficacy of turmeric against human ailments including lupus nephritis, cancer, diabetes, irritable bowel syndrome, acne, and fibrosis.

Study type
Narrative review
Who was studied
Human clinical trials, animal, and cell models (details not specified)
What was measured
Efficacy of turmeric in various diseases, biological activities, and targets

THE PAPER

Multitargeting by turmeric, the golden spice: From kitchen to clinic.

Gupta SC, Sung B, Kim JH, Prasad S, Li S, Aggarwal BB. Mol Nutr Food Res, 2013.

PubMed 22887802 ↗DOI 10.1002/mnfr.201100741 ↗

Diabetes & blood sugarCancerGut & microbiomeKidney healthOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.